Protalix BioTherapeutics
PLX
#7509
Rank
$83.27 M
Marketcap
$1.14
Share price
-3.39%
Change (1 day)
-53.47%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2023 (TTM): $11.75 M

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings (TTM) are $11.75 M. an increase over its 2022 earnings that were of -$11.87 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 2001 to 2023

Annual earnings

Year Earnings Change
2023$11.75 M-199.05%
2022-$11.87 M-40.38%
2021-$19.91 M-732.31%
2020$3.14 M-130.53%
2019-$10.31 M189.85%
2018-$3.56 M-95.29%
2017-$75.55 M308.12%
2016-$18.52 M-32.37%
2015-$27.38 M10.11%
2014-$24.86 M-7.59%
2013-$26.9 M
2011-$31.15 M-19.39%
2010-$38.65 M20.87%
2009-$31.97 M32.26%
2008-$24.18 M-5.46%
2007-$25.57 M
2004-$0.17 M12.35%
2003-$0.15 M-11.1%
2002-$0.17 M-57.03%
2001-$0.39 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$3.26 B 27,694.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.33 B 2,766.26%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.16 B-1,377.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.40 B 3,345.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel